239 related articles for article (PubMed ID: 8652399)
1. Transfusion-related acute lung injury due to HLA-A2-specific antibodies in recipient and NB1-specific antibodies in donor blood.
Bux J; Becker F; Seeger W; Kilpatrick D; Chapman J; Waters A
Br J Haematol; 1996 Jun; 93(3):707-13. PubMed ID: 8652399
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies.
Curtis BR; McFarland JG
Crit Care Med; 2006 May; 34(5 Suppl):S118-23. PubMed ID: 16617255
[TBL] [Abstract][Full Text] [Related]
3. TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities.
Davoren A; Curtis BR; Shulman IA; Mohrbacher AF; Bux J; Kwiatkowska BJ; McFarland JG; Aster RH
Transfusion; 2003 May; 43(5):641-5. PubMed ID: 12702187
[TBL] [Abstract][Full Text] [Related]
4. Transfusion-related acute lung injury caused by an NB2 granulocyte-specific antibody in a patient with thrombotic thrombocytopenic purpura.
Van Buren NL; Stroncek DF; Clay ME; McCullough J; Dalmasso AP
Transfusion; 1990 Jan; 30(1):42-5. PubMed ID: 2296790
[TBL] [Abstract][Full Text] [Related]
5. Recurrent transfusion-related acute lung injury.
Win N; Montgomery J; Sage D; Street M; Duncan J; Lucas G
Transfusion; 2001 Nov; 41(11):1421-5. PubMed ID: 11724989
[TBL] [Abstract][Full Text] [Related]
6. Investigating transfusion-related acute lung injury (TRALI).
Fung YL; Goodison KA; Wong JK; Minchinton RM
Intern Med J; 2003 Jul; 33(7):286-90. PubMed ID: 12823673
[TBL] [Abstract][Full Text] [Related]
7. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury.
; Bierling P; Bux J; Curtis B; Flesch B; Fung L; Lucas G; Macek M; Muniz-Diaz E; Porcelijn L; Reil A; Sachs U; Schuller R; Tsuno N; Uhrynowska M; Urbaniak S; Valentin N; Wikman A; Zupanska B
Vox Sang; 2009 Apr; 96(3):266-9. PubMed ID: 19207164
[TBL] [Abstract][Full Text] [Related]
8. Detection of anti-CD32 alloantibody in donor plasma implicated in development of transfusion-related acute lung injury.
Nishimura M; Takanashi M; Okazaki H; Satake M
Cell Biochem Funct; 2007; 25(2):179-83. PubMed ID: 16287215
[TBL] [Abstract][Full Text] [Related]
9. Transfusion-related acute lung injury (TRALI) after fresh frozen plasma in a patient with coagulopathy.
Lindgren L; Yli-Hankala A; Halme L; Koskimies S; Orko R
Acta Anaesthesiol Scand; 1996 May; 40(5):641-4. PubMed ID: 8792898
[TBL] [Abstract][Full Text] [Related]
10. HLA class II antibodies in transfusion-related acute lung injury.
Kopko PM; Popovsky MA; MacKenzie MR; Paglieroni TG; Muto KN; Holland PV
Transfusion; 2001 Oct; 41(10):1244-8. PubMed ID: 11606823
[TBL] [Abstract][Full Text] [Related]
11. The pathogenesis of transfusion-related acute lung injury (TRALI).
Bux J; Sachs UJ
Br J Haematol; 2007 Mar; 136(6):788-99. PubMed ID: 17341264
[TBL] [Abstract][Full Text] [Related]
12. A possible case of recipient anti-neutrophil and anti-human leukocyte antigen antibody-mediated fatal reverse transfusion-related acute lung injury.
Jug R; Anani W; Callum J
Transfusion; 2021 Apr; 61(4):1336-1340. PubMed ID: 33666248
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to the HLA-A2 antigen prime neutrophils and serve as the second event in an in vitro model of transfusion-related acute lung injury.
Silliman CC; Bercovitz RS; Khan SY; Kelher MR; LaSarre M; Land KJ; Sowemimo-Coker S
Vox Sang; 2014 Jul; 107(1):76-82. PubMed ID: 24372341
[TBL] [Abstract][Full Text] [Related]
14. Flow-cytometric approach to the prompt laboratory diagnosis of TRALI: a case report.
Porretti L; Coluccio E; Prati D; Colombo MB; Lopa R; Tombolini P; Ambrosone A; Crespiatico L; Scalamogna M; Rebulla P
Eur J Haematol; 2004 Oct; 73(4):295-9. PubMed ID: 15347317
[TBL] [Abstract][Full Text] [Related]
15. Transfusion-related acute lung injury (TRALI) induced by donor-derived anti-HLA antibodies in aplastic anemia: possible priming effect of granulocyte-colony stimulating factor (G-CSF) on the recipient neutrophils.
Hishizawa M; Mitsuhashi R; Ohno T
Intern Med; 2009; 48(22):1979-83. PubMed ID: 19915300
[TBL] [Abstract][Full Text] [Related]
16. Report on the second international granulocyte serology workshop.
Bux J; Chapman J
Transfusion; 1997 Sep; 37(9):977-83. PubMed ID: 9308648
[TBL] [Abstract][Full Text] [Related]
17. Prolonged neutropenia resulting from antibodies to neutrophil-specific antigen NB1 following marrow transplantation.
Stroncek DF; Shapiro RS; Filipovich AH; Plachta LB; Clay ME
Transfusion; 1993 Feb; 33(2):158-63. PubMed ID: 8430456
[TBL] [Abstract][Full Text] [Related]
18. Are we underestimating reverse TRALI?
De Clippel D; Emonds MP; Compernolle V
Transfusion; 2019 Sep; 59(9):2788-2793. PubMed ID: 31241780
[TBL] [Abstract][Full Text] [Related]
19. Rapid screening of granulocyte antibodies with a novel assay: flow cytometric granulocyte immunofluorescence test.
Nguyen XD; Flesch B; Sachs UJ; Kroll H; Klüter H; Müller-Steinhardt M
Transfusion; 2009 Dec; 49(12):2700-8. PubMed ID: 19659676
[TBL] [Abstract][Full Text] [Related]
20. Alloimmunization after granulocyte transfusions.
Stroncek DF; Leonard K; Eiber G; Malech HL; Gallin JI; Leitman SF
Transfusion; 1996; 36(11-12):1009-15. PubMed ID: 8937413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
